MR
About
Mary Rozenman is a Vice President at Longitude Capital. She focuses on investments in biotechnology. Prior to joining Longitude Capital in 2013, Dr. Rozenman was an Associate Principal at McKinsey & Company and a leader in the Healthcare and Corporate Finance practices. At McKinsey, she served clients in the biotechnology and medical technology industries on a variety of strategic and operational initiatives across commercial operations, research, clinical and corporate development. Dr. Rozenman also led the support of over $6 billion in healthcare transactions for McKinsey's leading private equity clients.
Position in the VCSift Database
- • 1 investors hold the SVP, Corporate and Commercial Development role in VCSift. Mary Rozenman is one of them.
- • 1,751 investors are based in California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- California, US
Contact Information
linkedin.com/in/••••••••
Find more investors like Mary
Search Investors